Effect of Chemoprevention by Low-dose Aspirin of New or Recurrent Colorectal Adenomas in Patients With Lynch Syndrome

NCT02813824 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

852

Enrollment

OTHER

Sponsor class

Conditions

Lynch Syndrome

Interventions

DRUG: Acetylsalicylic acid lysinate 300 mg
DRUG: Placebo (for Aspirin 300)
DRUG: Acetylsalicylic acid lysinate 100 mg
DRUG: Placebo 100 (for Aspirin 100)

Sponsor

Assistance Publique - Hôpitaux de Paris